mitoxantrone has been researched along with Atypical Ductal Hyperplasia in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone could cause an intrapleural inflammatory reaction." | 5.29 | [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy]. ( Blohmer, JU; Kohls, A; Lau, HU, 1993) |
| "Mitoxantrone could cause an intrapleural inflammatory reaction." | 1.29 | [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy]. ( Blohmer, JU; Kohls, A; Lau, HU, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blohmer, JU | 1 |
| Kohls, A | 1 |
| Lau, HU | 1 |
| Calais, G | 1 |
| Descamps, P | 1 |
| Chapet, S | 1 |
| Turgeon, V | 1 |
| Reynaud-Bougnoux, A | 1 |
| Lemarié, E | 1 |
| Fignon, A | 1 |
| Body, G | 1 |
| Bougnoux, P | 1 |
| Lansac, J | 1 |
2 other studies available for mitoxantrone and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
[Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy].
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Humans | 1993 |
Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, | 1993 |